Sun Pharma.Inds.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,885.10
-17.9 (-0.94%)
BSENSE

Nov 20

BSE+NSE Vol: 19.61 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,885.10",
    "chg": -17.9,
    "chgp": "-0.94%",
    "dir": -1,
    "prev_price": "1,903.00",
    "mcapval": "454,974.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE044A01036",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "19.61 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://researchintel.adityabirlamoney.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries Ltd Gains 0.22%: Mixed Technical Signals and Market Activity Shape the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-gains-022-mixed-technical-signals-and-market-activity-shape-the-week-4270483",
        "imagepath": "",
        "date": "2026-11-21 14:04:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Stock opens at Rs.1,866.95, declines 0.74%</p>\n                    <p><strong>18 Nov:</strong> Death Cross forms, signalling potential bearish trend</p>\n                    <p><strong>19 Nov:</strong> Sharp open interest surge amid bullish momentum</p>\n                    <p><strong>19 Nov:</strong> Mojo Grade downgraded to Sell</p>\n                    <p><strong>20 Nov:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,880.90</div></div>\n                    <div class=\"stat..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4268791",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SunPharmaceutic_technicaldot_4268791.png",
        "date": "2026-11-20 08:03:42",
        "description": "Sun Pharmaceutical Industries Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent upgrade in its technical outlook, the stock’s overall Mojo Grade has been downgraded from Hold to Sell, reflecting a complex interplay of bullish and bearish signals across multiple timeframes and indicators."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Sharp Open Interest Surge Amid Bullish Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-sharp-open-interest-surge-amid-bullish-momentum-4268563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SunPharmaceutic_oi_spurts_by_underlying_4268563.png",
        "date": "2026-11-19 15:00:59",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent outperformance relative to its sector and sustained gains over the past three sessions have coincided with this spike, prompting a closer examination of volume patterns, market positioning, and implications for investors."
      },
      {
        "title": "Sun Pharmaceutical Industries Downgraded to Sell Amid Technical and Financial Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sun-pharmaceutical-industries-downgraded-to-sell-amid-technical-and-financial-concerns-4267717",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SunPharmaceutic_mojoScore_4267717.png",
        "date": "2026-11-19 08:35:54",
        "description": "Sun Pharmaceutical Industries Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by a deterioration in technical indicators, flat financial performance, and valuation concerns. Despite its status as a large-cap leader in the Pharmaceuticals & Biotechnology sector, recent quarterly results and promoter stake reductions have raised caution among analysts, prompting a reassessment of the stock’s outlook."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-faces-mildly-bearish-technical-shift-amid-mixed-momentum-signals-4267525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SunPharmaceutic_technicaldot_4267525.png",
        "date": "2026-11-19 08:04:42",
        "description": "Sun Pharmaceutical Industries Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish stance to a mildly bearish outlook. Despite a modest day change of 0.12%, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid evolving market conditions."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-forms-death-cross-signalling-potential-bearish-trend-4267329",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SunPharmaceutic_dealthcross_4267329.png",
        "date": "2026-11-18 18:00:54",
        "description": "Sun Pharmaceutical Industries Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average, signalling a potential shift towards a bearish trend and long-term weakness in the stock’s price momentum."
      },
      {
        "title": "P/E at 36.45 vs Industry's 39.31: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-4266497",
        "imagepath": "",
        "date": "2026-11-18 09:20:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: A Slight Discount in a High-P/E Industry</strong></p>\n                <p><a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> trades at a P/E of 36.45, which is approximately 7.3% below the Pharmaceuticals & Biotechnology sector average of 39.31. This discount suggests that the market is pricing in either a more conservative growth outlook or risk factors relative to peers. Given the sector's elevated valuation levels, this positioning could reflect a cautious stance despite the company's large-cap status and established market presence. The P/E differential invites the question <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"ctx\">previously ra..."
      },
      {
        "title": "P/E at 36.39 vs Industry's 39.33: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-market-dynamics-4264909",
        "imagepath": "",
        "date": "2026-11-17 09:21:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: A Slight Discount in a High-P/E Sector</strong></p>\n                <p><a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> trades at a P/E of 36.39, which is approximately 7.5% below the Pharmaceuticals & Biotechnology sector average of 39.33. This valuation discount suggests the market is pricing in either a more cautious outlook on the company's near-term earnings growth or a premium being assigned elsewhere within the sector. The sector itself is characterised by elevated valuations, reflecting strong growth expectations and innovation-driven prospects. The stock’s relative valuation position raises the question <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.ind..."
      },
      {
        "title": "P/E at 36.78 vs Industry's 39.79: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-4260311",
        "imagepath": "",
        "date": "2026-11-13 09:21:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Slight Discount Amid Sector Premiums</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 36.78, which is approximately 7.6% below the sector average of 39.79. This valuation gap suggests that the stock is trading at a modest discount relative to its pharmaceutical peers. Given the sector's elevated valuations, this discount could reflect investor caution or a recalibration of growth expectations. The P/E differential is notable because it contrasts with the stock's large-cap status and its historical premium pricing. <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceut..."
      }
    ],
    "total": 378,
    "sid": "948699",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Nov-2026",
      "details": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "04-Nov-2026",
      "details": "Q2FY27 Earnings Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Clarification Sought From Sun Pharmaceutical Industries Ltd",
      "datetime": "02-Nov-2026",
      "details": "The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2 2026 with reference to news appeared in https://www.thehindu.com/ dated October 30 2026 quoting \"India orders Sun Pharma to halt eye-care drug production at plant after quality lapses\" .<BR><BR>The reply is awaited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Jul 26",
          "dt": "2026-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05-Nov-2026 | Source : BSE

Intimation of Schedule of Analyst/Institutional Investor Meeting

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

04-Nov-2026 | Source : BSE

Q2FY27 Earnings Call Transcript

Clarification Sought From Sun Pharmaceutical Industries Ltd

02-Nov-2026 | Source : BSE

The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2 2026 with reference to news appeared in https://www.thehindu.com/ dated October 30 2026 quoting "India orders Sun Pharma to halt eye-care drug production at plant after quality lapses" .

The reply is awaited.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sun Pharmaceutical Industries Ltd has declared 500% dividend, ex-date: 07 Jul 26

stock-summary
SPLITS

Sun Pharmaceutical Industries Ltd has announced 1:5 stock split, ex-date: 25 Nov 10

stock-summary
BONUS

Sun Pharmaceutical Industries Ltd has announced 1:1 bonus issue, ex-date: 29 Jul 13

stock-summary
RIGHTS

No Rights history available